SCHEMBL6423656

SCHEMBL6423656

Cc1c([C@H](CC2CCC2)C(=O)O)c2c(F)c(O)c(F)cc2n1C(=O)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.34
HSD11B1 P28845 1/20 0.33
HPGD P15428 1/20 0.33
LIPG Q9Y5X9 1/20 0.33
SIGMAR1 Q99720 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
APP P05067 1/20 0.32
PSEN1 P49768 1/20 0.32
PSEN2 P49810 1/20 0.32
APH1B Q8WW43 1/20 0.32
NCSTN Q92542 1/20 0.32
APH1A Q96BI3 1/20 0.32
PSENEN Q9NZ42 1/20 0.32
HTR1A P08908 1/20 0.32
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6424159 0.98 TSHR (0.34) TSHRHSD11B1HPGDLIPGSIGMAR1
SCHEMBL6456659 0.95 PDE2A (0.33) APPPSEN1PSEN2APH1BNCSTN
SCHEMBL6453537 0.93 PDE2A (0.33) APPPSEN1PSEN2APH1BNCSTN
SCHEMBL6425574 0.91 AKR1C3 (0.39) CYP1A2CYP2D6
SCHEMBL6423595 0.91 MEN1 (0.32) HSD11B1
SCHEMBL6428230 0.90 TSHR (0.34) TSHRHSD11B1HPGDAPPPSEN1
SCHEMBL6424288 0.90 AKR1C3 (0.39) CYP1A2CYP2D6
SCHEMBL6425954 0.90 USP30 (0.33) HSD11B1CYP3A4CYP2D6
SCHEMBL6424757 0.89 GPR142 (0.36) HSD11B1ALDH1A1
SCHEMBL6428226 0.88 TSHR (0.34) TSHRHSD11B1HPGDSIGMAR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors FAAH2, FAAH, PTGES2 TSHR 3525/4885HSD11B1 1120/4885HPGD 15/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.